Joni L. Rutter

7.6k total citations
51 papers, 3.3k citations indexed

About

Joni L. Rutter is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Joni L. Rutter has authored 51 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 19 papers in Cancer Research and 16 papers in Genetics. Recurrent topics in Joni L. Rutter's work include Protease and Inhibitor Mechanisms (10 papers), BRCA gene mutations in cancer (8 papers) and Cancer Genomics and Diagnostics (6 papers). Joni L. Rutter is often cited by papers focused on Protease and Inhibitor Mechanisms (10 papers), BRCA gene mutations in cancer (8 papers) and Cancer Genomics and Diagnostics (6 papers). Joni L. Rutter collaborates with scholars based in United States, United Kingdom and France. Joni L. Rutter's co-authors include Constance Brinckerhoff, Ulrike Benbow, James F. Gusella, Teresa I. Mitchell, Laurie J. Ozelius, Giovanna Butticè, Jacquelyn L. Meyers, Alan Buckler, Jeffery P. Struewing and Charles I. Coon and has published in prestigious journals such as Journal of Biological Chemistry, Nature Genetics and PLoS ONE.

In The Last Decade

Joni L. Rutter

51 papers receiving 3.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joni L. Rutter United States 28 1.5k 1.1k 844 649 260 51 3.3k
Trivadi S. Ganesan India 32 1.7k 1.1× 590 0.5× 1.2k 1.5× 254 0.4× 158 0.6× 166 3.8k
Jessica Wang‐Rodriguez United States 34 2.0k 1.3× 894 0.8× 959 1.1× 241 0.4× 120 0.5× 96 3.9k
Lukas Hefler Austria 42 1.2k 0.8× 774 0.7× 1.5k 1.8× 468 0.7× 89 0.3× 208 5.1k
Nicolaì Maass Germany 33 1.3k 0.9× 1.1k 1.0× 1.8k 2.2× 441 0.7× 112 0.4× 274 4.9k
Lotfi Chouchane Qatar 36 1.8k 1.2× 915 0.8× 1.2k 1.4× 805 1.2× 75 0.3× 155 4.3k
Robert S. Geske United States 22 2.6k 1.7× 267 0.2× 715 0.8× 700 1.1× 243 0.9× 37 4.5k
Emily O. Kistner United States 27 1.4k 0.9× 657 0.6× 571 0.7× 597 0.9× 128 0.5× 36 3.2k
William E. Russell United States 37 2.2k 1.4× 556 0.5× 1.4k 1.6× 1.1k 1.8× 651 2.5× 90 6.3k
Walter H. Gotlieb Canada 42 1.7k 1.1× 915 0.8× 1.6k 1.9× 440 0.7× 158 0.6× 244 6.4k
Marion Kiechle Germany 43 2.2k 1.5× 1.9k 1.6× 2.3k 2.8× 1.2k 1.8× 207 0.8× 311 6.2k

Countries citing papers authored by Joni L. Rutter

Since Specialization
Citations

This map shows the geographic impact of Joni L. Rutter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joni L. Rutter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joni L. Rutter more than expected).

Fields of papers citing papers by Joni L. Rutter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joni L. Rutter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joni L. Rutter. The network helps show where Joni L. Rutter may publish in the future.

Co-authorship network of co-authors of Joni L. Rutter

This figure shows the co-authorship network connecting the top 25 collaborators of Joni L. Rutter. A scholar is included among the top collaborators of Joni L. Rutter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joni L. Rutter. Joni L. Rutter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Buse, John B., et al.. (2023). A framework for assessing clinical trial site readiness. Journal of Clinical and Translational Science. 7(1). e151–e151. 6 indexed citations
2.
Mapes, Brandy, Christopher S. Foster, Sheila V. Kusnoor, et al.. (2020). Diversity and inclusion for the All of Us research program: A scoping review. PLoS ONE. 15(7). e0234962–e0234962. 156 indexed citations
3.
Khoury, Muin J., W Feero, David Chambers, et al.. (2018). A collaborative translational research framework for evaluating and implementing the appropriate use of human genome sequencing to improve health. PLoS Medicine. 15(8). e1002631–e1002631. 37 indexed citations
4.
Purohit, Vishnudutt, Rao S. Rapaka, Joni L. Rutter, & David Shurtleff. (2012). Do Opioids Activate Latent HIV-1 by Down-Regulating Anti-HIV microRNAs?. Journal of Neuroimmune Pharmacology. 7(3). 519–523. 19 indexed citations
5.
Saccone, Scott F., Laura J. Bierut, Elissa J. Chesler, et al.. (2009). Supplementing High-Density SNP Microarrays for Additional Coverage of Disease-Related Genes: Addiction as a Paradigm. PLoS ONE. 4(4). e5225–e5225. 21 indexed citations
6.
Volkow, Nora D., Joni L. Rutter, Jonathan D. Pollock, David Shurtleff, & Rubén Baler. (2008). One SNP linked to two diseases—addiction and cancer: A Double Whammy?: Nicotine addiction and lung cancer susceptibility. Molecular Psychiatry. 13(11). 990–992. 9 indexed citations
7.
Sahoo, Satya S., Olivier Bodenreider, Joni L. Rutter, Karen Skinner, & Amit Sheth. (2008). An ontology-driven semantic mashup of gene and biological pathway information: Application to the domain of nicotine dependence. Journal of Biomedical Informatics. 41(5). 752–765. 48 indexed citations
8.
Rutter, Joni L.. (2006). Symbiotic relationship of pharmacogenetics and drugs of abuse. The AAPS Journal. 8(1). E174–E184. 28 indexed citations
9.
Rutter, Joni L., Christina M. Bromley, Alisa M. Goldstein, et al.. (2004). Heterogeneity of risk for melanoma and pancreatic and digestive malignancies. Cancer. 101(12). 2809–2816. 24 indexed citations
10.
Nelson, Kristin K., Aparna C. Ranganathan, Ana M. Rodrı́guez, et al.. (2003). Elevated sod2 activity augments matrix metalloproteinase expression: evidence for the involvement of endogenous hydrogen peroxide in regulating metastasis.. PubMed. 9(1). 424–32. 114 indexed citations
11.
12.
Rutter, Joni L., et al.. (2003). CDKN2A point mutations D153spl(c.457G>T) and IVS2+1G>T result in aberrant splice products affecting both p16INK4a and p14ARF. Oncogene. 22(28). 4444–4448. 24 indexed citations
13.
Pfeiffer, Ruth M., et al.. (2002). Two approaches to mutation detection based on functional data. Statistics in Medicine. 21(22). 3447–3464. 14 indexed citations
14.
Noll, Walter W., Dorothy R. Belloni, Joni L. Rutter, et al.. (2001). Loss of Heterozygosity on Chromosome 11q22-23 in Melanoma Is Associated with Retention of the Insertion Polymorphism in the Matrix Metalloproteinase-1 Promoter. American Journal Of Pathology. 158(2). 691–697. 42 indexed citations
15.
16.
Sun, Yubo, Yi Sun, Leonor Wenger, et al.. (1999). Human Metalloproteinase‐1 (Collagenase‐1) Is a Tumor Suppressor Protein p53 Target Gene. Annals of the New York Academy of Sciences. 878(1). 638–641. 12 indexed citations
17.
Sun, Yubo, Yi Sun, Leonor Wenger, et al.. (1999). p53 Down-regulates Human Matrix Metalloproteinase-1 (Collagenase-1) Gene Expression. Journal of Biological Chemistry. 274(17). 11535–11540. 124 indexed citations
18.
Mitchell, Teresa I., et al.. (1999). Retinoid‐Mediated Suppression of Tumor Invasion and Matrix Metalloproteinase Synthesis. Annals of the New York Academy of Sciences. 878(1). 466–486. 26 indexed citations
19.
Menon, Anil G., Joni L. Rutter, Anat Blumenfeld, et al.. (1997). Frequent loss of chromosome 14 in atypical and malignant meningioma: identification of a putative `tumor progression' locus. Oncogene. 14(5). 611–616. 92 indexed citations
20.
Church, Deanna M., Christy Stotler, Joni L. Rutter, et al.. (1994). Isolation of genes from complex sources of mammalian genomic DNA using exon amplification. Nature Genetics. 6(1). 98–105. 225 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Trivadi S. Ganesan Breakdown of academic impact, for papers by Jessica Wang‐Rodriguez Breakdown of academic impact, for papers by Lukas Hefler Breakdown of academic impact, for papers by Nicolaì Maass Breakdown of academic impact, for papers by Lotfi Chouchane Breakdown of academic impact, for papers by Robert S. Geske Breakdown of academic impact, for papers by Emily O. Kistner Breakdown of academic impact, for papers by William E. Russell Breakdown of academic impact, for papers by Walter H. Gotlieb Breakdown of academic impact, for papers by Marion Kiechle
Rankless by CCL
2026